The benefits of physical activity and cardiovascular rehabilitation on the reduction of cardiovascular risk are well documented. Despite this, significant barriers and challenges remain in optimizing patient risk factors post acute coronary syndromes (ACS) and ensuring patient compliance. Consumer wearable personal activity trackers represent a cost effective and readily available technology that may aid in this endeavour.
UP-STEP ACS is a prospective single-blinded, two-arm, parallel, randomized control trial with an aim to enrol 200 patients all undertaking cardiac rehabilitation. It will assess the affect that personal activity monitors have on change in exercise capacity in patients post acute coronary syndromes primarily measured by a six-minute walk test (6MWT). Secondary end points will be the improvement in other cardiovascular risk factors, namely; blood lipid and glucose levels, weight, waist circumference, along with mood, quality of life and cardiac rehabilitation adherence. Patients will be randomized to either receive a personal activity tracker or standard post hospital care during their index event. After the 8- week intervention period, patients will return for a clinical review and repeat of baseline assessments including the 6MWT.
The utility and impact on exercise capacity of personal activity trackers in patient’s post-acute coronary syndrome has not been assessed. This study aims to add to the scientific evidence emerging regarding the clinical utility and validity of these devices in different patient population groups. If proven to be of benefit, these devices represent a cost effective, easily accessible technology that could aid in the reduction of cardiovascular events.
The trial has been registered with the Australian New Zealand Clinical Trials Registry (ANZCTR). The registration number is ACTRN12617000312347 (28/02/2017).
Lloyd-Jones DM, Hong Y, Labarthe D, Mozaffarian D, Appel LJ, Van Horn L, et al. Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association’s strategic impact goal through 2020 and beyond. Circulation. 2010;121(4):586–613. CrossRefPubMed
Pearson TA, Blair SN, Daniels SR, Eckel RH, Fair JM, Fortmann SP, et al. AHA guidelines for primary prevention of cardiovascular disease and stroke: 2002 update: consensus panel guide to comprehensive risk reduction for adult patients without coronary or other atherosclerotic vascular diseases. American Heart Association Science Advisory and Coordinating Committee. Circulation. 2002;106(3):388–91. CrossRefPubMed
AHA, ACC, National Heart, Lung, and Blood Institute, Smith SC Jr, Allen J, et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update endorsed by the National Heart, Lung, and Blood Institute. J Am Coll Cardiol. 2006;47(10):2130–9. CrossRef
Australian Institute of Health and Welfare AG. Leading causes of death. Available from: https://www.aihw.gov.au/deaths/. Accessed Apr 2017.
World Health Organisation. The top 10 causes of death. Fact Sheet. Available from: http://www.who.int/mediacentre/factsheets/fs310/en/. Accessed Mar 2017.
Aliprandi-Costa B, Ranasinghe I, Chow V, Kapila S, Juergens C, Devlin G, et al. Management and outcomes of patients with acute coronary syndromes in Australia and New Zealand, 2000-2007. Med J Aust. 2011;195(3):116–21. PubMed
Heran BS, Chen JM, Ebrahim S, Moxham T, Oldridge N, Rees K, et al. Exercise-based cardiac rehabilitation for coronary heart disease. Cochrane Database Syst Rev. 2011;7:CD001800.
Tavella R, Arstall M, Worthley M, Chew D, Zeitz C, Beltrame J. Determinants of cardiac rehabilitation referral following acute myocardial infarction in Australia. Circ Cardiovasc Qual Outcomes. 2015;8:A214.
Scotto CJ, Waechter D, Rosneck J. Factors affecting program completion in phase II cardiac rehabilitation. Can J Cardiovasc Nurs. 2011;21(2):15–20. PubMed
World Health Organisation. Global strategy on diet, physical activity and health. Physical activity and recommended levels of phsyical activity for adults aged 18–64 years. Geneva: World Health Organisation; 2011. Available from: http://www.who.int/dietphysicalactivity/factsheet_adults/en. Accessed Apr 2017.
Australian Burea of Statistics AG. Australian Health Survey: Physical activity, 2014–15. ABS Catalogue; 2015. p. 4363.0.
Statista. Forcast unit sales of health and fitness trackers worldwide from 2014–2014 (in millions), by region. 2015. Available from: http://www.statista.com/statistics/413265/health-and-fitness-trackerworldwide-unit-sales-region/. Accessed Apr 2017.
CCS Insight. Smart watches and smart bands dominate fast-growth wearables market. CCS Insight; 2014 [cited 2017. Available from: http://www.ccsinsight.com/press/company-news/1944-smartwatches-and-smart-bands-dominate-fast-growing-wearables-market. Accessed Apr 2017.
Ridgers ND, McNarry MA, Mackintosh KA. Feasibility and Effectiveness of Using Wearable Activity Trackers in Youth: A Systematic Review. JMIR Mhealth Uhealth. 2016;4(4):e129.
Endeavour Partners. Inside Wearables: How the science of human behavior change offers the secret to long-term engagement. Endeavour Partners; 2017 [Available from: https://blog.endeavour.partners/inside-wearable-how-the-science-of-human-behavior-change-offers-the-secret-to-long-term-engagement-a15b3c7d4cf3. Accessed Apr 2017.
National Heart Foundation Australia. Physical activity in patients with cardiovascular disease: management algorithm and information for general practice. . Available from: https://www.heartfoundation.org.au/images/uploads/publications/physical-activity-in-patients-with-cvd-management-algorithm.pdf. Accessed Apr 2017.
Grazzi GMG, Myers J, et al. Improved walking speed is associated with lower hospitalisation rates in patients in an exercise-based secondary prevention programme. Heart. 2016;102(23):1902–8.
Leung AA, Nerenberg K, Daskalopoulou SS, McBrien K, Zarnke KB, Dasgupta K, et al. Hypertension Canada’s 2016 Canadian hypertension education program guidelines for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension. Can J Cardiol. 2016;32(5):569–88. CrossRefPubMed
Ware JE Jr. SF-36 health survey update. Spine (Phila Pa 1976). 2000;25(24):3130–9. CrossRef
Markland D, Hardy L. The exercise motivations inventory: preliminary development and validity of a measure of individuals’ reasons for participation in regular physical exercise. Personal Individ Differ. 1993;15:289–96. CrossRef
Mittleman MA, Maclure M, Tofler GH, Sherwood JB, Goldberg RJ, Muller JE. Triggering of acute myocardial infarction by heavy physical exertion. Protection against triggering by regular exertion. Determinants of myocardial infarction onset study investigators. N Engl J Med. 1993;329(23):1677–83. CrossRefPubMed
Gremeaux V, Troisgros O, Benaim S, Hannequin A, Laurent Y, Casillas JM, et al. Determining the minimal clinically important difference for the six-minute walk test and the 200-meter fast-walk test during cardiac rehabilitation program in coronary artery disease patients after acute coronary syndrome. Arch Phys Med Rehabil. 2011;92(4):611–9. CrossRefPubMed
- The utility of personal activity trackers (Fitbit Charge 2) on exercise capacity in patients post acute coronary syndrome [UP-STEP ACS Trial]: a randomised controlled trial protocol
Paul Min Thein
- BioMed Central
Neu im Fachgebiet Kardiologie
e.Med Kampagnen-Visual, Mail Icon II